CCR3 and Zika virus infectious disease: Our data demonstrate that neutralizing antibodies and small-molecule CCR3/CCR5 receptor antagonists inhibit persistent ZIKV infection of hBMECs and as a result have the potential to prevent ZIKV spread to neuronal compartments and across placental barriers.